patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: emma, if we have enough operating capital to get

us through the FDA process I would rather we didn't license everything out right now. We may find we generate enough revenue to retain control internally and not have to share with anyone. That would be the optimum situation if we could pull it off.

Share
New Message
Please login to post a reply